JP2022546577A5 - - Google Patents

Info

Publication number
JP2022546577A5
JP2022546577A5 JP2022514522A JP2022514522A JP2022546577A5 JP 2022546577 A5 JP2022546577 A5 JP 2022546577A5 JP 2022514522 A JP2022514522 A JP 2022514522A JP 2022514522 A JP2022514522 A JP 2022514522A JP 2022546577 A5 JP2022546577 A5 JP 2022546577A5
Authority
JP
Japan
Prior art keywords
item
nucleic acid
region
amino acid
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022514522A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022546577A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/049538 external-priority patent/WO2021046445A1/en
Publication of JP2022546577A publication Critical patent/JP2022546577A/ja
Publication of JP2022546577A5 publication Critical patent/JP2022546577A5/ja
Pending legal-status Critical Current

Links

JP2022514522A 2019-09-05 2020-09-04 Bcmaと結合する二量体抗原受容体(dar) Pending JP2022546577A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201962896190P 2019-09-05 2019-09-05
US62/896,190 2019-09-05
US201962896990P 2019-09-06 2019-09-06
US62/896,990 2019-09-06
US201962910341P 2019-10-03 2019-10-03
US62/910,341 2019-10-03
US201962943069P 2019-12-03 2019-12-03
US62/943,069 2019-12-03
US202063030145P 2020-05-26 2020-05-26
US63/030,145 2020-05-26
PCT/US2020/049538 WO2021046445A1 (en) 2019-09-05 2020-09-04 Dimeric antigen receptors (dar) that bind bcma

Publications (2)

Publication Number Publication Date
JP2022546577A JP2022546577A (ja) 2022-11-04
JP2022546577A5 true JP2022546577A5 (cg-RX-API-DMAC10.html) 2023-09-11

Family

ID=74852154

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022514522A Pending JP2022546577A (ja) 2019-09-05 2020-09-04 Bcmaと結合する二量体抗原受容体(dar)

Country Status (10)

Country Link
US (1) US20220251168A1 (cg-RX-API-DMAC10.html)
EP (1) EP4025227A4 (cg-RX-API-DMAC10.html)
JP (1) JP2022546577A (cg-RX-API-DMAC10.html)
KR (1) KR20220057598A (cg-RX-API-DMAC10.html)
CN (1) CN114650829A (cg-RX-API-DMAC10.html)
AU (1) AU2020341712A1 (cg-RX-API-DMAC10.html)
CA (1) CA3149867A1 (cg-RX-API-DMAC10.html)
IL (1) IL291076A (cg-RX-API-DMAC10.html)
MX (1) MX2022002723A (cg-RX-API-DMAC10.html)
WO (1) WO2021046445A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210133261A (ko) * 2019-02-26 2021-11-05 소렌토 쎄라퓨틱스, 인코포레이티드 Bcma에 결합하는 항원 결합 단백질
EP4139345A1 (en) 2020-04-24 2023-03-01 Sorrento Therapeutics, Inc. Memory dimeric antigen receptors
US20240197881A1 (en) * 2021-04-23 2024-06-20 Sorrento Therapeutics, Inc. Dimeric Antigen Receptors (DARs) that Bind GD2
AR127743A1 (es) * 2021-09-06 2024-02-28 Genmab Bv Anticuerpos capaces de unirse a cd27, variantes y usos de los mismos
CN117986387A (zh) * 2023-05-31 2024-05-07 四川大学华西医院 一种新型小型化car设计及制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015166056A1 (en) * 2014-05-02 2015-11-05 Cellectis Cs1 specific multi-chain chimeric antigen receptor
CN107849102B (zh) * 2015-05-15 2022-05-13 希望之城 嵌合抗原受体组合物
US11173179B2 (en) * 2015-06-25 2021-11-16 Icell Gene Therapeutics Llc Chimeric antigen receptor (CAR) targeting multiple antigens, compositions and methods of use thereof
MX2018004721A (es) * 2015-10-23 2018-07-06 Eureka Therapeutics Inc Construcciones quimericas anticuerpo/receptor de celulas t y usos de las mismas.
AU2018290272A1 (en) * 2017-06-21 2020-01-30 Gsbio, Llc Heterodimeric bispecific antibodies
MA49911A (fr) * 2017-11-01 2020-06-24 Juno Therapeutics Inc Anticorps et récepteurs antigéniques chimériques spécifiques de l'antigene de maturation des lymphocytes b
SG11202008568WA (en) * 2018-03-09 2020-10-29 Sorrento Therapeutics Inc Dimeric antigen receptors (dar)
KR20210133261A (ko) * 2019-02-26 2021-11-05 소렌토 쎄라퓨틱스, 인코포레이티드 Bcma에 결합하는 항원 결합 단백질

Similar Documents

Publication Publication Date Title
Azuma Co-signal molecules in T-cell activation: historical overview and perspective
US11390658B2 (en) Anti-CD7 chimeric antigen receptor and method of use thereof
JP2020517295A5 (cg-RX-API-DMAC10.html)
US5686281A (en) Chimeric receptor molecules for delivery of co-stimulatory signals
JP2020511529A5 (cg-RX-API-DMAC10.html)
JP2021500881A5 (cg-RX-API-DMAC10.html)
JP2020533958A5 (cg-RX-API-DMAC10.html)
JP2024507996A5 (cg-RX-API-DMAC10.html)
US11760806B2 (en) CD-38 directed chimeric antigen receptor constructs
JP2024527557A5 (cg-RX-API-DMAC10.html)
JP2022534680A5 (cg-RX-API-DMAC10.html)
JP2018535701A5 (cg-RX-API-DMAC10.html)
US20200399393A1 (en) Dimeric Antigen Receptors
JP2018529376A5 (cg-RX-API-DMAC10.html)
JP2022530773A5 (cg-RX-API-DMAC10.html)
JP2017524367A5 (cg-RX-API-DMAC10.html)
RU2017109966A (ru) Условно активные химерные антигенные рецепторы для модифицированных т-клеток
JP2024534847A5 (cg-RX-API-DMAC10.html)
JP7723420B2 (ja) B細胞標的化並列CAR(pCAR)治療的薬剤
EP4196231A1 (en) Chimeric antigen receptor t cells for treating autoimmunity
US20240261330A1 (en) CD19-Directed Chimeric Antigen Receptor Constructs
US20240173411A1 (en) Methods for treating cd83-expressing cancer
JP2023516595A5 (cg-RX-API-DMAC10.html)
Teschner Use of TCR antibody fusion proteins as bispecific agents for NK and T cell-mediated immunotherapy
WO2025081163A1 (en) Compositions for the treatment of cancer